First-of-its-Kind custom cancer vaccine tested in patients
Disease control
Completed
This early-stage study tested a new, personalized vaccine for melanoma, a serious skin cancer. The vaccine was custom-made for each of the 15 participants using the unique genetic features of their own tumor. The main goals were to see if creating and giving this vaccine was safe…
Phase: PHASE1 • Sponsor: Patrick Ott, MD, PhD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC